IMCD completed the acquisition of Trichem.

IMCD, a company specializing in the distribution and formulation of speciality chemicals and ingredients, completed the acquisition of Trichem, a supplier of pharmaceutical APIs and intermediates. Financial terms were not disclosed. "With India being a major supplier of the world’s generic drugs, this acquisition further enhances our portfolio, in particular with active pharmaceutical ingredients, and reinforces our position in the region’s life-sciences industry. Additionally, we are excited to welcome Trichem’s talented team, whose deep market expertise and strong industry relationships will be invaluable to IMCD," Narendra Varde, IMCD India Managing Director.